These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35032088)

  • 41. Iodinated Contrast Agents Reduce the Efficacy of Intravenous Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients: a Multicenter Cohort Study.
    Chen Z; Xu C; Zhong W; Gong X; Hu H; Zhang X; Chen Y; Li Q; Luo Z; Chen Z; Lou M
    Transl Stroke Res; 2021 Aug; 12(4):530-539. PubMed ID: 32895894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of blood coagulation and thrombin generation in acute ischemic stroke treated with rtPA.
    Goldman S; Prior SM; Bembenek JP; Niewada M; Broniatowska E; Członkowska A; Butenas S; Undas A
    J Thromb Thrombolysis; 2017 Oct; 44(3):362-370. PubMed ID: 28879581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutrophil extracellular traps mediated by platelet microvesicles promote thrombosis and brain injury in acute ischemic stroke.
    Gao X; Zhao X; Li J; Liu C; Li W; Zhao J; Li Z; Wang N; Wang F; Dong J; Yan X; Zhang J; Hu X; Jin J; Mang G; Ma R; Hu S
    Cell Commun Signal; 2024 Jan; 22(1):50. PubMed ID: 38233928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet-Neutrophil Association in NETs-Rich Areas in the Retrieved AIS Patient Thrombi.
    Pir GJ; Parray A; Ayadathil R; Pananchikkal SV; Mir FA; Muhammad I; Abubakar A; Amir N; Hussain S; Haroon KH; Muhammad A; Imam Y; Patro SN; Akhtar N; Zakaria A; Kamran S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrasound-responsive theranostic platform for the timely monitoring and efficient thrombolysis in thrombi of tPA resistance.
    Lin L; Ba Z; Tian H; Qin H; Chen X; Zhou X; Zhao S; Li L; Xue F; Li H; He L; Li X; Du J; Zhou Z; Zeng W
    Nat Commun; 2024 Aug; 15(1):6610. PubMed ID: 39098904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive value of coagulation factor XIII on bleeding risk in ischemic stroke patients treated with intravenous thrombolysis.
    Zhang L; Zhang C; Luo Y; Tang N
    Ann Palliat Med; 2021 Jul; 10(7):7579-7586. PubMed ID: 34353045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-specific trends in intravenous thrombolysis and mechanical thrombectomy utilization in acute ischemic stroke in children under age 18.
    Kaur N; Patel S; Ayanbadejo MO; Hoffman H; Akano E; Anikpezie N; Aneni E; Lamikanra O; Wee C; Albright K; Khandelwal P; Latorre JG; Chaturvedi S; Otite FO
    Int J Stroke; 2023 Apr; 18(4):469-476. PubMed ID: 36250237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.
    Szegedi I; Orbán-Kálmándi R; Nagy A; Sarkady F; Vasas N; Sik M; Lánczi LI; Berényi E; Oláh L; Crișan A; Csiba L; Bagoly Z
    PLoS One; 2021; 16(7):e0254253. PubMed ID: 34234378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In silico study of combination thrombolytic therapy with alteplase and mutant pro-urokinase for fibrinolysis in ischemic stroke.
    Yang Y; Gu B; Xu XY
    Comput Biol Med; 2024 Mar; 171():108141. PubMed ID: 38367449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
    J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.
    Stan A; Dragos H; Strilciuc S; Ilut S; Vacaras V; Cozma A; Panaitescu PS; Stan H; Muresanu DF
    CNS Neurol Disord Drug Targets; 2023; 22(10):1493-1506. PubMed ID: 36200200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of acute ischemic stroke: from fibrinolysis to neurointervention.
    Jacquin GJ; van Adel BA
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S290-6. PubMed ID: 26149038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Floating arterial thrombus related stroke treated by intravenous thrombolysis.
    Vanacker P; Cordier M; Janbieh J; Federau C; Michel P
    Cerebrovasc Dis; 2014; 38(2):117-20. PubMed ID: 25278110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efforts to reduce the door-to-needle time of thrombolysis in acute ischemic stroke: video-assisted therapeutic risk communication.
    Hsieh CY; Chen WF; Chen CH; Wang CY; Chen CJ; Lai EC; Chen TS
    J Formos Med Assoc; 2014 Dec; 113(12):929-33. PubMed ID: 24412584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Permeable Thrombi Are Associated With Higher Intravenous Recombinant Tissue-Type Plasminogen Activator Treatment Success in Patients With Acute Ischemic Stroke.
    Santos EM; Dankbaar JW; Treurniet KM; Horsch AD; Roos YB; Kappelle LJ; Niessen WJ; Majoie CB; Velthuis B; Marquering HA;
    Stroke; 2016 Aug; 47(8):2058-65. PubMed ID: 27338928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutrophil Counts to High-Density Lipoprotein Cholesterol Ratio: a Potential Predictor of Prognosis in Acute Ischemic Stroke Patients After Intravenous Thrombolysis.
    Chen G; Yang N; Ren J; He Y; Huang H; Hu X; Shen J; Yang C; Zeng T; Hu J; Tong W; Yang D; Zhang Y
    Neurotox Res; 2020 Dec; 38(4):1001-1009. PubMed ID: 32894456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. YangXueQingNaoWan attenuated blood brain barrier disruption after thrombolysis with tissue plasminogen activator in ischemia stroke.
    Yao SQ; Ye Y; Li Q; Wang XY; Yan L; Huo XM; Pan CS; Fu Y; Liu J; Han JY
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117024. PubMed ID: 37572928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.
    Alessi MC; Gaudin C; Grosjean P; Martin V; Timsit S; Mahagne MH; Larrue V; Sibon I; Zuber M; Brouns R; Montaner J; Castellanos M; Donazzolo Y; Cho TH; Suissa L; Mechtouff L; Derex L; Suchon P; Mezzapesa A; Nighoghossian N
    Cerebrovasc Dis; 2016; 42(5-6):404-414. PubMed ID: 27387478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.